newsfilter
← Latest News
PR Newswire·

Akcea Announces Appointment of New Chief Financial Officer

Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., today announced that Michael D. Price has joined...